DOPA AND 5-S-CYSTEINYLDOPA IN URINE IN HEALTHY HUMANS

被引:0
|
作者
AGRUP, G
RORSMAN, H
FALCK, B
KENNEDY, BM
ROSENGREN, AM
ROSENGREN, E
机构
[1] UNIV GOTHENBURG, DEPT DERMATOL, GOTHENBURG, SWEDEN
[2] UNIV LUND, DEPT ANAT, LUND, SWEDEN
[3] UNIV LUND, DEPT DERMATOL, LUND, SWEDEN
[4] UNIV LUND, DEPT BIOCHEM, LUND, SWEDEN
[5] UNIV LUND, DEPT PHARMACOL, LUND, SWEDEN
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:453 / 454
页数:2
相关论文
共 50 条
  • [31] IMPROVED HPLC DETERMINATION OF 5-S-CYSTEINYLDOPA IN SERUM
    WAKAMATSU, K
    ITO, S
    CLINICAL CHEMISTRY, 1994, 40 (03) : 495 - 496
  • [32] Serum concentration of 5-S-cysteinyldopa in patients with melanoma
    Bánfalvi, T
    Gilde, K
    Boldizsár, M
    Fejös, Z
    Horváth, B
    Liszkay, G
    Beczássy, E
    Kremmer, T
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2000, 30 (10) : 900 - 904
  • [33] 5 YEARS EXPERIENCE OF 5-S-CYSTEINYLDOPA IN MELANOMA DIAGNOSIS
    AGRUP, G
    AGRUP, P
    ANDERSSON, T
    HAFSTROM, L
    HANSSON, C
    JACOBSSON, S
    JONSSON, PE
    RORSMAN, H
    ROSENGREN, AM
    ROSENGREN, E
    ACTA DERMATO-VENEREOLOGICA, 1979, 59 (05) : 381 - 388
  • [34] PLASMA 5-S-CYSTEINYLDOPA CONCENTRATIONS IN OCULOCUTANEOUS ALBINISM
    NIMMO, JE
    HUNTER, JAA
    PERCYROBB, IW
    JAY, B
    PHILLIPS, CI
    TAYLOR, WOG
    ACTA DERMATO-VENEREOLOGICA, 1985, 65 (02) : 169 - 171
  • [35] METABOLISM OF 5-S-CYSTEINYLDOPA BY O-METHYLATION
    AGRUP, G
    FALCK, B
    HANSSON, C
    RORSMAN, H
    ROSENGREN, AM
    ROSENGREN, E
    ACTA DERMATO-VENEREOLOGICA, 1977, 57 (04) : 309 - 312
  • [36] CHARACTERIZATION OF MELANOGENESIS IN MOUSE HAIR BY CHEMICAL-ANALYSIS OF MELANINS AND OF FREE AND BOUND DOPA AND 5-S-CYSTEINYLDOPA
    ITO, S
    FUJITA, K
    TAKAHASHI, H
    MAEDA, K
    JIMBOW, K
    YALE JOURNAL OF BIOLOGY AND MEDICINE, 1984, 57 (03): : 372 - 373
  • [37] 5-S-CYSTEINYLDOPA AND PIGMENT RESPONSE TO UVA LIGHT
    TEGNER, E
    RORSMAN, H
    ROSENGREN, E
    ACTA DERMATO-VENEREOLOGICA, 1983, 63 (01) : 21 - 25
  • [38] Serum 5-S-cysteinyldopa in patients with metastatic melanoma
    Horikoshi, T
    Ito, S
    Wakamatu, K
    Onodera, H
    Hanada, N
    Hamaoka, S
    Eguchi, H
    MELANOGENESIS AND MALIGNANT MELANOMA: BIOCHEMISTRY, CELL BIOLOGY, MOLECULAR BIOLOGY, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, 1996, 1096 : 151 - 159
  • [39] THE STABILITY OF 5-S-CYSTEINYLDOPA AND 6-HYDROXY-5-METHOXYINDOLE-2-CARBOXYLIC ACID IN HUMAN URINE
    KAGEDAL, B
    LENNER, L
    ARSTRAND, K
    HANSSON, C
    PIGMENT CELL RESEARCH, 1992, : 304 - 307
  • [40] PARADOXES AND PITFALLS IN THE INTERPRETATION OF PLASMA 5-S-CYSTEINYLDOPA LEVELS
    NIMMO, JE
    GAWKRODGER, DJ
    ODOHERTY, CS
    PERCYROBB, IW
    HUNTER, JAA
    BRITISH JOURNAL OF DERMATOLOGY, 1984, 111 (06) : 705 - 705